191 related articles for article (PubMed ID: 27463003)
1. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α
Li J; Chen Q; He X; Alam A; Ning J; Yi B; Lu K; Gu J
J Transl Med; 2018 Mar; 16(1):78. PubMed ID: 29566706
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice.
Gu J; Chen J; Xia P; Tao G; Zhao H; Ma D
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1272-8. PubMed ID: 22092133
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms.
Ma J; Chen Q; Li J; Zhao H; Mi E; Chen Y; Yi B; Ning J; Ma D; Lu K; Gu J
Anesth Analg; 2020 Apr; 130(4):1054-1062. PubMed ID: 30346356
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
Li Q; Chen C; Chen X; Han M; Li J
Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via α
Shan X; Zhang J; Wei X; Tao W; Peng K; Liu H; Wang Y; Liu H; Meng X; Ji F
FASEB J; 2022 Nov; 36(11):e22608. PubMed ID: 36250975
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.
Bell MT; Puskas F; Bennett DT; Herson PS; Quillinan N; Fullerton DA; Reece TB
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):500-6. PubMed ID: 24035379
[TBL] [Abstract][Full Text] [Related]
10. Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II.
Wu Z; Wang Z; Dai F; Liu H; Ren W; Chang J; Li B
Mediators Inflamm; 2016; 2016():8696481. PubMed ID: 28119542
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.
Si Y; Bao H; Han L; Shi H; Zhang Y; Xu L; Liu C; Wang J; Yang X; Vohra A; Ma D
J Transl Med; 2013 Jun; 11():141. PubMed ID: 23759023
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin Ameliorates Lung Injury by Accelerating Pulmonary Endothelium Cell Proliferation via Janus Kinase-Signal Transducer and Activator of Transcription 3 Pathway After Kidney Ischemia and Reperfusion Injury.
Zhu M; Wang L; Yang J; Xie K; Zhu M; Liu S; Xu C; Wang J; Gu L; Ni Z; Xu G; Che M
Transplant Proc; 2019 Apr; 51(3):972-978. PubMed ID: 30979490
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway.
Ren Y; Li L; Wang MM; Cao LP; Sun ZR; Yang ZZ; Zhang W; Zhang P; Nie SN
Int Immunopharmacol; 2021 Nov; 100():108077. PubMed ID: 34464887
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury.
Jiang Y; Xia M; Xu J; Huang Q; Dai Z; Zhang X
Immunol Res; 2021 Apr; 69(2):162-175. PubMed ID: 33641076
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of murine acute lung injury by PF-573,228, an inhibitor of focal adhesion kinase.
Lederer PA; Zhou T; Chen W; Epshtein Y; Wang H; Mathew B; Jacobson JR
Vascul Pharmacol; 2018 Nov; 110():16-23. PubMed ID: 29969688
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- γC- terminal fragments.
Guo X; Eitnier RA; Beard RS; Meegan JE; Yang X; Aponte AM; Wang F; Nelson PR; Wu MH
PLoS One; 2020; 15(4):e0231739. PubMed ID: 32352989
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice.
Gu J; Sun P; Zhao H; Watts HR; Sanders RD; Terrando N; Xia P; Maze M; Ma D
Crit Care; 2011 Jun; 15(3):R153. PubMed ID: 21702944
[TBL] [Abstract][Full Text] [Related]
19. Adenosine diphosphate ribosylation factor 6 inhibition protects burn sepsis induced lung injury through preserving vascular integrity and suppressing ASC inflammasome transmission.
Xiao M; Zhang P; Chen Z; Liu X; Wei W; He Z; Wang Y; Cheng J; Zhu Z; Wen J; Yang H
Burns; 2024 May; 50(4):913-923. PubMed ID: 38267288
[TBL] [Abstract][Full Text] [Related]
20. Roles of VE-Cadherin in Hypoxia Induced Injury of Pulmonary Microvascular Endothelial Barrier.
Zhong L; Gao X; Chen Y; Yu Z; Jin S; Zhu C
Heart Surg Forum; 2021 Aug; 24(4):E764-E768. PubMed ID: 34473045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]